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The developmental mechanisms underlying human
congenital heart disease (CHD) are poorly under-
stood. Atrial septal defects (ASDs) can result from
haploinsufficiency of cardiogenic transcription fac-
tors including TBX5. We demonstrated that Tbx5
is required in the second heart field (SHF) for atrial
septation in mice. Conditional Tbx5 haploinsuffi-
ciency in the SHF but not the myocardium or endo-
cardium caused ASDs. Tbx5 SHF knockout embryos
lacked atrial septumprogenitors.We found that Tbx5
mutant SHF progenitors demonstrated cell-cycle
progression defects and that Tbx5 regulated cell-
cycle progression genes including Cdk6. Activated
hedgehog (Hh) signaling rescued ASDs in Tbx5
mutant embryos, placing Tbx5 upstream or parallel
to Hh in cardiac progenitors. Tbx5 regulated SHF
Gas1 and Osr1 expression, supporting both path-
ways. These results describe a SHF Tbx5-Hh
network required for atrial septation. A paradigm
defining molecular requirements in SHF cardiac
progenitors for cardiac septum morphogenesis has
implications for the ontogeny of CHD.
INTRODUCTION
Current understanding of the transcriptional regulation of cardiac
development (reviewed in Olson, 2006) has yet to illuminate the
molecular ontogeny of congenital heart disease (CHD). Long-
standing genetic studies have implicated dominant mutations
in transcription factor genes TBX5, NKX2-5, and GATA4 in
human congenital atrial septal defects (ASDs) (Basson et al.,
1997; Garg et al., 2003; Li et al., 1997; Schott et al., 1998),
a common form of CHD. Elegant work has demonstrated that
these transcription factors are expressed in the atrium during
atrial septation, physically interact to form a macromolecular
complex, and combinatorially activate atrial gene expression
(Bruneau et al., 2001; Garg et al., 2003; Hiroi et al., 2001; Take-
uchi and Bruneau, 2009). These observations support an intra-280 Developmental Cell 23, 280–291, August 14, 2012 ª2012 Elseviecardiac paradigm for atrial septation in which normal intracar-
diac transcription factor dose is essential for morphogenesis of
the atrial septum. However, the molecular and developmental
mechanisms describing how reduced cardiac transcription fac-
tor dose caused ASDs remain unknown.
Haploinsufficiency of TBX5 causes Holt-Oram syndrome,
characterized by structural cardiac and limb abnormalities (Bas-
son et al., 1997; Li et al., 1997). The majority of patients have
cardiac defects and ASDs are the most common, accounting
for approximately half (Bruneau et al., 1999). In a well-estab-
lished Tbx5 mouse model, 40% of mice haploinsufficient for
Tbx5 demonstrated ASDs (Bruneau et al., 2001). Several Tbx5
target genes have been identified, including Gja1, Gja5, and
Nppa, but none appear to regulate the development of the atrial
septum (Bruneau, 2003; Bruneau et al., 2001; Garg et al., 2003).
Thus, the pathogenesis of cardiac structural abnormalities re-
sulting from Tbx5 haploinsufficiency remains unclear.
The developmental basis of atrial septum formation and ASD
ontogeny has undergone significant recent revision. ASDs occur
in different structural variants including secundum ASDs, in the
region of the primary atrial septum (PAS), and primum ASDs,
a type of atrioventricular septal defect (AVSD) in the region of
the dorsal mesenchymal protrusion (DMP) (Anderson et al.,
2003). Recent work has underscored the importance of the
DMP in atrial and atrioventricular septation. Prior to formal atrial
septation, the developing DMP is extracardiac mesenchyme
associated with the dorsal mesocardium at the venous pole of
the heart (E9–10 in the mouse). The DMP protrudes into the
dorsal aspect of the atrial cavity, remains continuous with the
primary atrial septum, and resides as a prominent structure in
the posterior aspect of the mature atrioventricular mesenchymal
complex at the completion of atrial septation (Snarr et al., 2007a).
Recent work has correlated the deficiency of the DMP with
primum ASDs, including the septal defects commonly associ-
ated with Down syndrome (Blom et al., 2003; Goddeeris et al.,
2008; Hoffmann et al., 2009; Mommersteeg et al., 2006; Snarr
et al., 2007b; Wessels et al., 2000). The DMP is marked by
second heart field (SHF) markers Mef2c-Cre (Goddeeris et al.,
2008) and Isl1-Cre (Snarr et al., 2007b) and is generated by
a Hedgehog (Hh)-receiving lineage (Hoffmann et al., 2009).
SHF Hh-signaling is required for atrial septation (Goddeeris
et al., 2008; Hoffmann et al., 2009) and posterior SHF (pSHF)
cardiac progenitors receiving Hh-signaling generate the atrialr Inc.
Figure 1. Tbx5 Is Expressed in the Posterior Second Heart Field
Expression of Tbx5 andGli1 analyzed by in situ hybridization onwild-typemouse embryos in sagittal sections at E9.0 (A–D) and transverse sections at E10.0 (E–L).
Tbx5 (C and G) andGli1 (D and H) were both expressed in the DMP and the splanchnic mesoderm. Tbx5 (I and K) but notGli1 (J and L) was also expressed in the
heart. Magnification: (A), (B), (E), (F), (I), (J) = 1003; (C), (D), (G), (H), (K), (L) = 4003.
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Tbx5-Hh Heart Field Pathway in Atrial Septationseptum specifically (Hoffmann et al., 2009). These observations
engender a working hypothesis that specification of a subset
of pSHF progenitor cells specific for the atrial septum is a driver
of the atrial septum morphogenesis days later in the heart
proper.
We have implicated Tbx5 in the pSHF upstream and parallel to
Hh-signaling in atrial septation. We show that although myocar-
dial or endocardial Tbx5 haploinsufficiency had no structural
consequences, SHF Tbx5 haploinsufficiency recapitulated the
ASDs caused by germline Tbx5 haploinsufficiency. SHF Tbx5
knockout caused a failure of DMP formation. Tbx5 was required
for cell-cycle progression of pSHF atrial septum progenitors.
Remarkably, ASDs in Tbx5 mutant embryos were rescued
by constitutive Hh-signaling in atrial progenitors. We identified
Tbx5-responsive loci Gas1, required for normal Hh-signaling,
and Osr1, required for atrial septation, as Tbx5 targets. These
results place Tbx5 upstream of and parallel to Hh-signaling in
SHF atrial septum progenitors required for atrial septation and
provide molecular support for a recent paradigm describing
inflow tract CHDs as the result of SHF defects.
RESULTS
Tbx5 Is Expressed in the Posterior SHF Including
Gli1-Expressing Cells
Cardiac expression of Tbx5 is well documented in mice from E8
into adulthood, although its expression in the SHF has not been
examined in detail (Bruneau et al., 1999; Li et al., 1997). We eval-
uated Tbx5 expression in the SHF at E9 and E10 (Figure 1).
Strong Tbx5 expression was observed in the posterior SHF
(pSHF), DMP, and dorsal mesocardium surrounding the DMP
at E9 (Figures 1A and 1C). Tbx5 expression was observed in
the pSHF, dorsal mesocardium, and the primary atrial septum
(PAS) at E10 (Figures 1E and 1G). Tbx5was expressed bilaterally
in the SHF but extended more dorsally on the right side than the
left side (Figure 1G). Consistent with previous reports, strong
Tbx5 expression was also observed in the atria and the left
ventricle (Bruneau et al., 1999). Expression of Gli1, a memberDevelopof the Gli transcription factor family responsible for Hh signal
transduction and a marker of Hedgehog-receiving atrial septum
progenitors (Hoffmann et al., 2009), was observed in a bilaterally
symmetric pattern that overlapped with Tbx5 expression ven-
trally in the pSHF.
Tbx5 Is Not Required in theMyocardium or Endocardium
for Atrial Septation
We hypothesized that Tbx5may be required in the SHF for atrial
septation, not within the heart. We tested this hypothesis by
analyzing mice haploinsufficient for Tbx5 in the germline, myo-
cardium, endocardium, or SHF. We observed primum ASDs in
40% of Tbx5 germline haploinsufficient (Tbx5/+) embryos in
a mixed genetic background (5/12) at E13.5, when atrial septa-
tion is normally complete (Figures 2K–2N), consistent with previ-
ously published results (Bruneau et al., 2001). The pulmonary
veins appeared structurally normal in each case. We tested
whether Tbx5was required for atrial septation in themyocardium
using Tnt:Cre (Jiao et al., 2003), which drives Cre expression
throughout differentiated cardiac myocardium by E9.5 (Jiao
et al., 2003), to knock out a single loxP- flanked conditional allele
of Tbx5 (Tbx5fl/+) (Bruneau et al., 2001) (Figures 2A–2D). A re-
combined Tbx5 null allele was observed in heart tissue from
Tbx5Tnt-Cre/+ embryos by E9.5 (Figure 2I). Normal atrial septation
was observed in all Tbx5Tnt-Cre/+ (7/7) and littermate control
Tbx5fl/+ embryos (7/7) at E13.5 (p = 1) (Figure 2C versus 2D).
Tbx5Tnt-Cre/+ mutant embryos demonstrated thinner compact
ventricular myocardium (Figure 2A versus 2B), consistent with
the known requirement for Tbx5 in myocardial proliferation
(Goetz et al., 2006; Hatcher et al., 2001). We tested whether
Tbx5 was required for atrial septation in endocardium by
analyzing mice haploinsufficient for Tbx5 in the endocardium
using Tie2:Cre (Kisanuki et al., 2001), which drives Cre expres-
sion throughout vascular endothelium including endocardial
cushion endocardium by E9.5. A recombined Tbx5 null allele
was observed in hearts from Tbx5Tie-Cre/+ embryos by E9.5 (Fig-
ure 2J). Normal atrial septation was observed in all Tbx5Tie2-Cre/+
mutant embryos (7/7) and littermate control Tbx5fl/+ embryosmental Cell 23, 280–291, August 14, 2012 ª2012 Elsevier Inc. 281
Figure 2. Tbx5 Is Not Required in the Myocardium
or Endocardium but Is Required in SHF Hh-
Receiving Cells for Atrial Septation
(A–H) Analysis of atrial septation in myocardial or endo-
cardial Tbx5mutant embryos. Atrial septation was normal
in Tbx5fl/+ (A, C, E, G; 7/7), Tbx5Tnt-Cre/+ embryos (B, D; 7/7;
p = 1), and Tbx5Tie2-Cre/+ (F,H; 7/7; p = 1) embryos at E13.5.
(I and J) Cre-dependent somatic recombination of condi-
tional Tbx5 locus. At both E9.5 and E10.5, hearts from
Tbx5Tnt-Cre/+ (I) and Tbx5Tie2-Cre/+ (J) demonstrated a Tbx5
null allele (blue arrow, 480 bp band) and Cre expression
(green arrow head, 220 bp band) in the heart (lane 2, 3) but
not the tail (lane 1). Both the heart and tail DNA showed
Tbx5 wild-type (black arrow: 158 bp band) and Tbx5-flox
(red arrow: 198 bp band) alleles.
(K–R) Atrial septal defects in germline and SHF Tbx5
mutant embryos. Primum ASDs were observed in 40%
of Tbx5/+ embryos, consistent with previous reports
(Bruneau et al., 2001), (L and N) (5/12; p = 0.0466) and
40% of Tbx5Gli1Cre-ERT2/+ embryos (P and R) (5/12)
compared to 0% of Tbx5fl/+ embryos (O and Q) (0/7;
p = 0.0466) at E13.5 in transverse sections. Magnification:
(A), (B), (E), (F), (K), (L), (O), (P) = 403; (C), (D), (G), (H), (M),
(N), (Q), (R) = 1003.
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Tbx5-Hh Heart Field Pathway in Atrial Septation(7/7) at E13.5 (p = 1) (Figure 2G versus 2H), consistent with
previous reports (Nadeau et al., 2010). These results demon-
strated that Tbx5 haploinsufficiency in myocardium or endocar-
dium supported normal atrial septation.
Tbx5 Is Required in the SHF for Atrial Septation
We predicted that the dominant requirement for Tbx5 in atrial
septation might occur in SHF cardiac progenitors. We previ-
ously identified pSHF atrial septum progenitors as Hh-receiving
cells, defined by Gli1Cre-ERT2/+ expression (Hoffmann et al.,
2009). We evaluated atrial septation in embryos conditionally
haploinsufficient for Tbx5 in the pSHF using Gli1Cre-ERT2.
Tbx5Gli1Cre-ERT2/+ embryos and their littermate controls were
administered tamoxifen to activate Cre-ERT2 at E7.5 and
E8.5. ASDs were observed in 40% (5/12) of Tbx5Gli1CreE-RT2/+
embryos but no littermate control Tbx5fl/+ embryos at E13.5
(0/7; p = 0.0466) (Table 1; Figures 2O–2R). Because Gli1CreERT2
is a knockin allele, it was formally possible that the ASDs were
caused by a combined deficiency of Tbx5 and Hh-signaling,
not Tbx5 haploinsufficiency alone. Therefore, we directly tested
for a genetic interaction between Tbx5 and Gli1 in atrial septa-
tion by analyzing Tbx5/+; Gli1Cre-ERT2/+ embryos. ASD inci-
dence was no different in Tbx5/+ versus Tbx5/+; Gli1Cre-ERT2/+
embryos (5/12 versus 5/11; p = 0.8547) and no new cardiac282 Developmental Cell 23, 280–291, August 14, 2012 ª2012 Elsevier Inc.defects were observed in compound heterozy-
gotes, suggesting that presence of the Gli1
knockin allele had no discernible effect on the
incidence or expression of phenotypes caused
by Tbx5 haploinsufficiency (Table 1). Nonethe-
less, these results implicate either Tbx5 alone
or Tbx5 with Hh signaling in atrial septum
progenitors. Together with the exclusion of the
requirement for Tbx5 from the myocardiumand endocardium, these results place the requirement for Tbx5
in atrial septation in the SHF.
Tbx5 Is Essential for DMP Development
To examine the cellular mechanism by which Tbx5 haploinsuffi-
ciency caused ASDs, we performed genetic inducible fate map-
ping (GIFM) of atrial septum progenitors in Tbx5 germline het-
erozygotes. PSHF atrial septum progenitors were marked by
Gli1CreERT2/+ expression in combination with the Cre-dependent
lacZ reporter alleleR26R (Soriano, 1999). The effect of Tbx5 hap-
loinsufficiency on the number anddistribution of themarked atrial
septum progenitors was analyzed in Tbx5/+; R26RGli1Cre-ERT2/+
mutant and compared to R26RGli1Cre-ERT2/+ littermate controls.
b-galactosidase-expression was induced by tamoxifen adminis-
tration at E7.5 and E8.5 and descendants of marked atrial
septum progenitors were analyzed at E10.5 in the DMP. A hypo-
plastic DMP was observed in Tbx5/+; R26RGli1Cre-ERT2 embryos
(Figures 3A and 3C versus Figures 3B and 3D). b-galactosidase-
positive cells were decreased by 50% in the DMPof Tbx5mutant
embryos (187.4 ± 11.5 versus 92.4 ± 24.1, p = 0.0265) (Figure 3E).
Thus, Tbx5 haploinsufficiency caused a decrease in the number
of cells generated by the pSHF atrial septum progenitor lineage.
We next analyzed the requirement for Tbx5 in SHF cardiac
progenitors. We created conditional SHF Tbx5 knockouts using
Table 1. Incidence of ASDs in Tbx5 Mutant Embryos
Genotype ASD Total p Value (c2 Test)
Conditional Haploinsufficiency of Tbx5
Tbx5/+ 5 12 Tbx5/+ (5/12): Tbx5+/+(0/7) p = 0.0466
Tbx5Tnt-Cre/+ 0 7 Tbx5Tnt-Cre/+(0/7): Tbx5/+ (5/12) p = 0.0466
Tbx5Tie2-Cre/+ 0 7 Tbx5Tnt-Cre/+(0/7): Tbx5/+ (5/12) p = 0.0466
Tbx5Gli1cre-ERT2/+ 5 12 Tbx5Gli1cre-ERT2/+(5/12): Tbx5fl/+(0/7) p = 0.0466
Tbx5Gli1cre-ERT2/+(5/12):Tbx5/+ (5/12) p = 1
Tbx5/+;Gli1CreERT2/+ 5 11 Tbx5/+;Gli1CreERT2/+(5/11): Tbx5/+ (5/12) p = 0.8547
Tbx5Mef2c-Cre/+ 0 7 Tbx5Mef2c-Cre/+ (0/7): Tbx5fl/+ (0/7) p = 1
Conditional Knockout of Tbx5 in the SHF
Tbx5Gli1cre-ERT2 5 5 Tbx5Gli1cre-ERT2(5/5): Tbx5fl/fl(0/7) p = 0.0005
Tbx5Gli1cre-ERT2(5/5): Tbx5Gli1cre-ERT2/+ (5/11) p = 0.0367
Tbx5Mef2c-Cre 5a 5a Tbx5Mef2c-Cre (5/5): Tbx5fl/fl(0/7) p = 0.0005a
Smo-Tbx5 Compound Mutant Embryos
Tbx5/+; Smo/+ 7 8 Tbx5/+; Smo/+ (7/8): Tbx5/+ (5/12) p = 0.0404
Tbx5/+;Smo/+ (7/8): Smo/+ (0/7) p = 0.0007
Tbx5Gli1cre-ERT2/+; R26-SmoM2Gli1cre-ERT2/+ 0 11 Tbx5Gli1cre-ERT2/+; R26-SmoM2Gli1cre-ERT2/+(0/11) p = 0.0109
Tbx5Gli1cre-ERT2/+(5/11)
Tbx5Gli1cre-ERT2; R26-SmoM2Gli1cre-ERT2/+ 1 5 Tbx5Gli1cre-ERT2; R26-SmoM2Gli1cre-ERT2/+(1/5) p = 0.0098
Tbx5Gli1cre-ERT2(5/5)
Incidence of ASDs was evaluated in Tbx5mutant embryos at E13.5 or E14.5. Significance in ASD incidence between Tbx5mutant embryos and litter-
mate controls was analyzed by c2 test. ASD, atrial septal defects; DMP, dorsal mesenchymal protrusion; SHF, second heart field.
aEmbryos were examined at E10.5; severely hypoplastic DMPs were observed in all embryos.
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Tbx5-Hh Heart Field Pathway in Atrial Septationtwo SHF Cre lines, Mef2c:Cre (Verzi et al., 2005) and Gli1:Cre-
ERT2. In Tbx5Mef2c-Cre embryos, Tbx5 expression was abolished
in the pSHF and DMP (Figures 3G and 3I versus Figures 3F and
3H, black arrow) but maintained in the atrial and ventricular wall
(Figures 3F and 3G, red arrowhead). The DMP was absent or
extremely hypoplastic in all Tbx5Mef2c-Cre embryos (5/5)
compared to littermate Tbx5fl/fl controls (0/7; p = 0.0005) at
E10.5 (Table 1; Figures 3J and 3L versus Figures 3K and 3M).
We analyzed the effect of SHF Tbx5 knockout on the SHF fate
map and found that Tbx5 is absolutely required for the pSHF
lineage as defined by Mef2c:Cre expression: b-galactosidase-
expressing cells were entirely absent from the DMP region of
Tbx5Mef2c-Cre embryos at E9.5 (Figures 3Q versus 3P). ASDs
were also observed in all Tbx5Gli1Cre-ERT2 embryos at E10.5
(Table 1) (5/5; p = 0.0005 versus Tbx5fl/fl). These results demon-
strate a requirement for Tbx5 in development of the DMP utilizing
two independent SHF Cre-drivers.
Tbx5 Is Required for Proliferation of Atrial Septum
Progenitors
Plausible mechanisms for absence of the pSHF lineage in Tbx5
mutants included altered proliferation or apoptosis; we therefore
assessed both in Tbx5 mutant embryos. Proliferation was as-
sessed in wild-type and Tbx5/+ embryos by counting BrdU
incorporated cells in the pSHF and DMP at E9.5. We found
44% less BrdU-positive SHF cells in Tbx5/+ embryos than in
wild-type control embryos (Figures 4A–4E, 61.4%± 4.3% versus
34% ± 5.7%, p = 0.001). We next assessed the requirement for
Tbx5 specifically in atrial septumprogenitors by combiningGIFM
(Joyner and Zervas, 2006) with conditional SHF Tbx5 knockout.
Dual BrdU/b-galactosidase positive cells, indicative of prolifer-Developating atrial septum progenitors, were much more frequent in
R26RGli1Cre-ERT2/+ control embryos than in Tbx5Gli1Cre-ERT2;
R26RGli1Cre-ERT2/+ mutant embryos (Figure 4F, 34.9% ± 8.4%
versus 21.6% ± 5.6%, p = 0.0492). No apoptosis was observed
in Hh-receiving cells within the pSHF of either Tbx5Gli1Cre-ERT2;
R26RGli1Cre-ERT2/+ or R26RGli1Cre-ERT2/+ littermate control em-
bryos as analyzed by TUNNEL staining (Figure S1 available
online). Together, these findings define a requirement for Tbx5
in proliferation but not survival of pSHF cardiac progenitors.
Distinct Tbx5-Dependent Transcripts in the SHF and the
Heart
To identify Tbx5-dependent molecular networks required for
atrial septation, we compared the pSHF transcriptomes of
wild-type and Tbx5/+ mutant embryos. We microdissected
the heart, pSHF, and anterior SHF (aSHF) from E9.5 embryos
and molecularly verified our dissections by real-time PCR.
We observed a 35.8-fold higher Tbx5 expression in the pSHF
versus the aSHF, consistent with the selective expression of
Tbx5 in the pSHF (Figures 1A and 1C). Transcriptional profiling
of pSHF samples was performed on Agilent Mouse Whole
Genome Arrays (n = 4 WT pools and 4 Tbx5/+ pools). The R
statistical package SAM was used to detect differentially ex-
pressed genes (Tusher et al., 2001) and revealed upregulation
of 343 genes and downregulation of 672 genes with >2-fold
changes and false discovery rates <5% in Tbx5/+ versus control
pSHF (Table S1). Real-time PCR for 55 selected transcripts
confirmed significant expression changes in 47 genes (87%; Fig-
ure 5 and data not shown). Tbx5 expression was50% reduced
in both the heart and pSHF of Tbx5 heterozygotes, as expected
(Figures 4G and 4H). Expression of Gja5 and Nppa, previouslymental Cell 23, 280–291, August 14, 2012 ª2012 Elsevier Inc. 283
Figure 3. Tbx5 Is Required in SHF Hh-Receiving Cells for Atrial Septation
(A–E) Hh-receiving cardiac fate map in Tbx5 mutant embryos. Hh-receiving cells were marked by b-galactosidase expression in R26RGli1Cre-ERT2/+ embryos at
E7.5 and E8.5 by tamoxifen administration and analyzed by at E10.5. All b-galactosidase positive cells in the dorsal mesenchymal protrusion (DMP) (red arrows in
C and D) were counted. Significantly fewer b-gal positive DMP cells were present in Tbx5/+; R26RGli1Cre-ERT2/+ embryos (187.4 ± 11.5) Data are presented as
mean ± SEM, n = 3–4. (B and D) compared to R26RGli1Cre-ERT2/+ embryos (92.4 ± 24.1, p = 0.0265) (A and C).
(F–I) Tbx5 expression in SHF Tbx5mutant embryos. Tbx5 expression is extinguished specifically in the DMP and SHF of Tbx5Mef2c-Cre but notMef2cCre/+ embryos
at E9.5 by in situ hybridization. Myocardial Tbx5 expression is maintained in both genotypes (F and G red arrows).
(J–M) SHF Tbx5 expression is required for DMP development. The DMP was a well-defined structure in Tbx5fl/fl embryos (L, black arrow; 5/5) but absent in
Tbx5Mef2c-Cre embryos (K and M; 0/5; p = 0.0005).
(N–Q) Absence of SHF fate map in Tbx5 SHF mutant embryos. b-galactosidase expressing cells are absent from the pSHF including the DMP region in
Tbx5Mef2c-Cre;R26RMef2c-Cre/+ embryos (Q, black arrow) but present in control R26RMef2c-Cre/+ embryos (P, black arrow) at E9.5. b-galactosidase positive cells are
observed in the anterior SHF, outflow tract, and right ventricles in both genotypes (N and P versus O and Q). Data are presented as mean ± SEM, n = 3–4.
Magnification: (A), (B), (F), (G), (J), (K), (N), (O) = 1003; (C), (D), (H), (I), (L), (M), (P), (Q) = 4003.
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Tbx5-Hh Heart Field Pathway in Atrial Septationidentified Tbx5 downstream targets in the heart (Bruneau et al.,
2001; Mori et al., 2006), were significantly decreased in the heart,
but not in the pSHF. Expression of Gata6 andMef2cwere signif-
icantly decreased in the pSHF, but not in the heart at E9.5
(Figures 4G and 4H). These results suggested that pSHF and
heart Tbx5-dependent transcriptomes might be distinct.
Repression of interphase mitotic cell cycle, mitotic sister chro-
matid segregation, and G1-S transition of mitotic cell cycle were
identified by gene set enrichment analysis (GSEA) (Efron and Tib-
shirani, 2001) of Tbx5-dependent transcripts. Transcriptional
profiling identified 14 differentially expressed cell-cycle genes
and each was verified by real-time PCR (Figures 4I and 4J).
Cdk2, Cdk6, Cdk8, Cdc25a, PCNA, and Tfdp2, promoters of
the G1 to S transition (Malumbres and Barbacid, 2005; Xiong
et al., 1992), were downregulated whereas Cdkn2a, a repressor
of G1 to S transition (Chan et al., 1995), was upregulated in
the Tbx5/+ pSHF (Figure 4I). Cdca2, Cdc26, Cdc27, Cdk5rap,
Anapc1, Anapc10, and Cenpe all regulate M to G1 phase transi-
tion (Dong et al., 2007; Barr et al., 2010; Pe´rez-Pe´rez et al., 2008;
Rao et al., 2009; Vagnarelli et al., 2006; Wehman et al., 2007) and
were misexpressed in the Tbx5/+ pSHF transcriptome (Fig-
ure 4J). These results demonstrated that Tbx5 is required for284 Developmental Cell 23, 280–291, August 14, 2012 ª2012 Elsevienormal transcriptional control of genes required for cell-cycle
progression in the pSHF, and suggested that a pSHF cell cycle
defect in Tbx5 mutant embryos may mechanistically underlie
the observed ASDs.
Tbx5 Controls Cell-Cycle Progression of Atrial Septum
Progenitors
We tested the hypothesis that Tbx5 regulates pSHF cell-cycle
progression by analyzing phosphorylated-Ser10-H3-histone
(H3S10) immunohistochemistry, which differentially marks mi-
totic cells in G2 and M phase (Crosio et al., 2002): punctate
in G2 phase (Figures 4M–4Mm0 and 4N–4Nn0, red arrow-
head) and homogeneous in M phase (Figures 4M and 4N, white
arrowhead). We observed 44% fewer mitotic cells in the mu-
tant Tbx5Gli1Cre-ERT2; R26RGli1Cre-ERT2/+ pSHF than the control
R26RGli1Cre-ERT2/+ pSHF (7.73 ± 0.51% versus 4.25 ± 0.71%,
p = 0.0037; Figures 4N and 4P versus 4M and 4O). There was
no difference in the number of cells in G2 phase (12.03 ±
1.68% versus 10.03 ± 1.25%; p = 0.8744). We concluded that
Tbx5 is required for pSHF mitotic cell-cycle progress.
We hypothesized that Tbx5 may promote cell-cycle progress
by directly regulating cell-cycle component transcription.r Inc.
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Tbx5-Hh Heart Field Pathway in Atrial SeptationCdk6, a cyclin-dependent kinase, was identified as a candidate
based on its Tbx5-dependent pSHF expression (Figure 4I). We
used the overlap of evolutionary conservation and Tbx5 binding
sites from ChIP-seq studies in the HL-1 cardiomyocyte cell line
(He et al., 2011) to identify a conserved canonical Tbx5 binding
site (Table S2) in proximity to the Cdk6 promoter (Figure 4R).
Tbx5 transactivated luciferase expression from a Cdk6 genomic
fragment containing this site 10-fold compared to vector alone
(p = 0.009) (Figure S4; Table S2). This result suggests that Tbx5
promotes pSHF proliferation by directly regulating cell-cycle
gene transcription.
Hh-Signaling Rescues Atrial Septation in Tbx5 SHF
Mutant Embryos
The requirement for Tbx5 in Hh-receiving cells (Figure 3) sug-
gested that Tbx5 andHh-signaling might interact in atrial septum
progenitor specification. We tested this hypothesis by analyzing
an intercross between Tbx5/+ and Smo/+, encoding the obli-
gate Hh receptor. Smo/+ mice have quantitatively depressed
Hh-signaling, but do not have structural cardiac defects (Zhang
et al., 2001). We observed a significant increase in ASD inci-
dence in Smo/+; Tbx5/+ double heterozygotes (7/8) (Table 1;
Figures 5A–5D) compared to either Tbx5/+ (5/12; p = 0.0404)
or Smo/+ (0/7; p = 0.0005) (Figures 5A and 5C) single heterozy-
gotes at E14.5.
To elucidate the hierarchy between Tbx5 and Hh-signaling,
we performed epistasis analysis. We combined conditional
Tbx5 SHF haploinsufficiency or knockout with conditional SHF
activation of Hh-signaling by Cre-dependent expression of
SmoM2, a constitutively activated Smo mutant (Mao et al.,
2006). In control R26-SmoM2Gli1Cre-ERT2/+ embryos, normal
septation was observed at E14.5 (10/10) (Figures 5F and 5H).
Constitutive Hh-signaling rescued atrial septation in conditional
SHF Tbx5 heterozygotes: ASDs were observed in 0% of
Tbx5Gli1Cre-ERT2/+; R26-SmoM2Gli1Cre-ERT2/+ embryos (0/11) in
contrast to 40% of Tbx5Gli1Cre-ERT2/+ embryos (5/12, p = 0.01)
(Table 1; Figures 5J and 5L versus Figures 5I and 5K).
Remarkably, constitutive Hh-signaling rescued atrial septation
in Tbx5 SHF knockout embryos. ASDs were observed in only
20% of Tbx5Gli1Cre-ERT2; R26-SmoM2Gli1Cre-ERT2/+ embryos
(1/5) in contrast to 100% of Tbx5Gli1Cre-ERT embryos (5/5;
p value = 0.01) (Figures 5N and 5P versus Figures 5M and
5O). The observation that Hh-signaling can rescue atrial septa-
tion in Tbx5 SHF knockout embryos suggested that Tbx5 acts
upstream or in parallel to Hh- signaling in SHF atrial septum
progenitors.
We hypothesized that Hh-signaling may rescue atrial sep-
tation by correcting the cell-cycle defect in Tbx5 mutant
embryos. We analyzed atrial septum progenitor cell-cycle
progression in the presence and absence of constitutive Hh-
signaling in Tbx5 mutant embryos. We quantitated M phase
H3S10 positive cells in 800 SHF atrial septum progenitors
at E9.5 in each genotype. There was no significant difference
in the number of H3S10 positive cells in the structurally nor-
mal Smo-M2Gli1Cre-ERT2/+ (5.71 ± 0.54%) compared to control
Gli1CreERT2/+ embryos (6.16 ± 0.75%, p = 0.63) (Figure 5Q). In
contrast, a significant proliferation defect was observed in
mutant Tbx5Gli1Cre-ERT2 embryos (4.21% ± 0.15%), as expected
(Figure 4). The proliferation decrement observed in Tbx5Developmutants was rescued in Tbx5Gli1Cre-ERT2; Smo-M2Gli1Cre-ERT2/+
embryos (5.66% ± 0.23%, p = 0.017). The number of H3S10
positive atrial septum progenitors in Tbx5Gli1Cre-ERT2; Smo-
M2Gli1Cre-ERT2/+ embryos (5.66 ± 0.23%) was not different than
that observed in control Gli1CreERT2/+ embryos (6.16 ± 0.75%;
p = 0.274) (Figure 5Q). These results suggest that activated
Hh-signaling rescues the morphologic defects in Tbx5 mutant
embryos by a mechanism that includes normalization of cell
proliferation.
Tbx5 Acts Upstream and Parallel to Hh-Signaling in
the SHF
We sought molecular evidence for the SHF Tbx5-Hh-signaling
hierarchy. If Tbx5 acted upstream of Hh-signaling, we predicted
that quantitative markers for Hh-signaling would be decreased
in Tbx5 mutants. To assess the integrity of Hh-signaling, we
quantitatively evaluated Hh-dependent transcripts Patched1
(Ptch1), the primary Hh membrane receptor, and Gli1. Ptch1
and Gli1 expression were both significantly reduced in the
pSHF of Tbx5Mef2c-cre mutant embryos by real-time PCR (Fig-
ure 6A), consistent with a requirement for Tbx5 upstream of
Hh-signaling. We hypothesized that Tbx5 may directly regulate
Hh-signaling components and examined the expression of the
known Hh-signaling pathway members at or upstream of
Smo, including Smo, Boc, Gas1, and Cdo (Allen et al., 2011;
Izzi et al., 2011). We found that expression of Gas1, but not
the other candidate genes, was significantly decreased in the
pSHF of Tbx5Mef2c-Cre mutant embryos (Figure 6A and data
not shown). We hypothesized that Gas1 may be a direct Tbx5
target. We bioinformatically interrogated the Gas1 locus to iden-
tify potential Tbx5-responsive elements, utilizing the overlap of
evolutionary conservation and ChIP-seq studies identifying
Tbx5 binding sites in the atrial cardiomyocyte HL-1 cell line
(He et al., 2011) and identified a conserved canonical Tbx5
binding site (Table S2) in proximity to the Gas1 promoter. We
found that Tbx5 significantly transactivated luciferase expres-
sion from a Gas1 genomic region containing this site (Figure
6B; Table S2). Vector alone demonstrated no Tbx5-dependent
activation in vitro (Figure 6B). Together, these results suggest
that Tbx5 potentates pSHF Hh-signaling by a mechanism that
includes activation of Gas1 expression. However, the Tbx5
mutant phenotype could not be explained by the observed
partial loss of Hh-signaling (Figure 6A), suggesting that Tbx5
may act parallel to Hh-signaling in addition to hierarchically in
the SHF.
We identified odd-skipped related-1 (Osr1), encoding a zinc
finger transcription factor (Wang et al., 2005), as a candidate
Tbx5 and Hh-signaling target gene in the SHF required for atrial
septation. Osr1mutant mice demonstrated absence of the atrial
septum (Wang et al., 2005) and Osr1 is upregulated in a Tbx5
overexpression model (Plageman and Yutzey, 2006). We found
that Osr1 expression was significantly reduced in the pSHF of
both Tbx5/+ and Shh/ mutant embryos by real-time PCR at
E9.5 (Figure 6H). We tested whether Osr1 was a direct Tbx5
target. We bioinformatically interrogated the Osr1 locus to iden-
tify potential Tbx5-responsive elements using overlap of evolu-
tionary conservation and previously identified Tbx5 binding sites
in the cardiomyocyte HL-1 cell line (He et al., 2011). We identi-
fied and cloned four distinct regions with Tbx5 binding sitesmental Cell 23, 280–291, August 14, 2012 ª2012 Elsevier Inc. 285
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Figure 5. Hh-Signaling Is Epistatic to Tbx5 in Atrial
Septation
(A–D) Genetic interaction between Tbx5 and Smo in atrial
septation. Tbx5/+; Smo/+ embryos (A and D) demon-
strated significantly more ASDs (7/8) than Tbx5/+ em-
bryos (5/12; p = 0.0404) or Smo/+ embryos (A and C) (0/7;
p = 0.0007) at E14.5.
(E–P) Rescue of ASDs in Tbx5 SHF mutant embryos by
constitutive Hh-signaling. Primum ASDs were observed
in 40% of Tbx5Gli1Cre-ERT2/+ (I and K; 5/12) but 0% of
R26-SmoM2 Gli1Cre-ERT2/+;Tbx5Gli1Cre-ERT2/+ embryos (J
and L) (p = 0.0098). Primum ASDs were observed in
100% of Tbx5Gli1Cre-ERT2 (M and O; 5/5) but 20% of R26-
SmoM2 Gli1Cre-ERT2/+; Tbx5Gli1Cre-ERT2 embryos (N and P)
(1/5; p = 0.0109). No heart defects were observed in
Gli1CreERT2/+ or R26-SmoM2 Gli1Cre-ERT2/+ embryos.
(Q) The decreased percentage of phosphorylated H3-
histone positive b-galactosidase positive pSHF cells
in Tbx5Gli1Cre-ERT2, R26RGli1Cre-ERT2/+ embryos com-
pared to Gli1CreERT2/+ or R26-SmoM2Gli1Cre-ERT2/+,
R26RGli1Cre-ERT2/+ embryos was normalized in R26-
SmoM2Gli1Cre-ERT2/+, Tbx5Gli1Cre-ERT2, R26RGli1Cre-ERT2/+
embryos at E9.5. Data are presented as mean ± SEM,
n = 3–4.
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ure 6K); no other Tbx5 binding sites were encountered for an
additional 300 kb downstream or in the upstream intergenicFigure 4. Tbx5 Is Required for Cell-Cycle Progress of Posterior SHF Cardiac Progenitor
(A–F) PSHF proliferation requires Tbx5. Fewer pSHF BrdU incorporated cells were observed in Tbx5
versus 34% ± 5.7%, p = 0.001). Fewer BrdU and Hh-receiving b-galactosidase pSHF comarked
embryos than in R26RGli1Cre-ERT2/+ embryos (34.9% ± 8.4% versus 21.6% ± 5.6%, p = 0.0492). Data
(G–J) Distinct Tbx5-dependent transcripts in the pSHF and heart at E9.5 by real-time PCR. Tbx5 was
Gja5were downregulated in the heart but not the pSHF (G and H).Gata6 andMef2cwere downregulat
that promote G1-S progress (Cdk2,Cdk6,Cdk25a, PCNA, Tfbp2) were downregulated whereas a gen
Data are presented as mean ± SEM, n = 3–4.
(K–Q) Tbx5 is required for cell-cycle progression in Hh-receiving pSHF cells. Significantly fewer b-gala
inM-phase by anti-Histone-H3 (H3S10) immunohistochemistry inR26RGli1Cre-ERT2/+; Tbx5Gli1Cre-ERT2 e
arrowheads mark cells in mitosis diffuse nuclear staining) (7.73 ± 0.51% versus 4.25 ± 0.71%, p = 0.00
(M and N, red arrowhead marking cell in G2 phase with punctate nuclear staining) (15.31 ± 2.23% vers
and b-galactosidase costained cells in the pSHF and DMP region. Magnification: (A), (B), (K), (L) = 10
(R) Schematic of mouseCdk6 including Tbx5 binding region (He et al., 2011) adjacent toCdk6 promote
expression (green bar). Data are presented as mean ± SEM, n = 3–4.
(S) Tbx5 significantly stimulated firefly luciferase expression from the Cdk6 promoter region compare
p < 0.009). Data are presented as mean ± SEM, n = 3.
See also Figure S1 and Tables S1 and S2.
Developmental Cell 23, 2region. We found that Tbx5 significantly trans-
activated luciferase expression from two of the
four Osr1 cloned genomic regions, Osr1F1
and Osr1F4 (Figure 6I; Table S2), but not from
the two other regions (Osr1F2 or Osr1F3) or
vector alone (Figure 6I; Table S2). We next
asked if Tbx5 physically occupies the Tbx5-
responsive Osr1 genomic regions in the SHF
in vivo during atrial septum progenitor specifi-
cation. We performed ChIP-PCR for Tbx5
from the pSHF at E10.5, microdissected from
50 wild-type embryos. ChIP-PCR demon-
strated significant Tbx5-dependent enrichment
for the Osr1F1 fragment, containing three
canonical Tbx5 binding sites (Figure 6J; TableS2), and the Osr1F4 fragment, containing a single canonical
Tbx5 binding site (Figure 6J; Table S2). These results identify
Osr1 as a direct downstream target of Tbx5 in the SHF ands
/+ (B, D, E) than wild-type embryos (A, C, E) (61.4% ± 4.3%
cells were observed in Tbx5Gli1Cre-ERT2;R26RGli1Cre-ERT2/+
are presented as mean ± SEM, n = 3–4.
downregulated in the heart and pSHF (G and H). Nppa and
ed in the posterior SHF but not in the heart. (I and J) Genes
e that represses G1-S progress (Cdkn2a)was upregulated.
ctosidase marked pSHF Hh-receiving cells were observed
mbryos than inR26RGli1Cre-ERT2/+ embryos (N andM, white
37). There was no difference in the number of late G2 cells
us 14.60 ± 1.94%, p = 0.9237). (Q) Quantification of H3S10
03; (C), (D), (M)–(P) = 4003.
r and cloned genomic fragment tested for Tbx5-dependent
d to pGL3-vector control (10.55 ± 4.27 versus 1.28 ± 0.49,
80–291, August 14, 2012 ª2012 Elsevier Inc. 287
Figure 6. Tbx5 Act Upstream and Parallel to Hh-signaling in Atrial
Septation
(A) Decreased expression of Hh-dependent genes in the SHF of Tbx5 mutant
embryos. Ptch, Gli1, and Gas1 expression were significantly decreased in
Tbx5/+ embryos at E9.5 by real-time PCR. Data are presented as mean ±
SEM, n = 3–4.
(B) Tbx5 significantly stimulated firefly luciferase expression from the Gas1
promoter region compared to pGL3-vector control (4.288 ± 1.43 versus
1.424 ± 0.357, p < 0.05). Data are presented as mean ± SEM, n = 3.
(C) Schematic of mouse Gas1 including Tbx5 binding region (He et al., 2011)
adjacent to Gas1 promoter and the cloned genomic fragment tested for Tbx5-
dependent expression in vitro (green bar). See also Table S2.
(D–G) Expression ofOsr1 analyzed by in situ hybridization on wild-type mouse
embryos by whole mount at E9 (D) and E10 (E) and sagittal sections at E9.5
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for atrial septation.
DISCUSSION
Tbx5 Is Required in the SHF: Implications for the
Ontogeny of ASDs
In this study, we have demonstrated that the requirement for
Tbx5 in atrial septation lies in the pSHF. Tbx5 was expressed
robustly in the pSHF, in atrial septum progenitors marked by
Gli1 expression (Figure 1) (Hoffmann et al., 2009). Haploinsuffi-
ciency of Tbx5 in Hh-receiving pSHF cells caused primum
ASDs identical to those observed in Tbx5/+ embryos (Figure 2)
and Tbx5 knockout in the pSHF or atrial septum progenitors
caused absence of the DMP, the structural anlage of the ventral
atrial septum (Figure 3). This structural abnormality may have
been caused by a proliferation defect of atrial progenitors,
whose mitotic cell-cycle progress was impeded in Tbx5 mutant
embryos (Figure 4). Atrial septation in Tbx5 mutant embryos
was rescued by constitutive Hh-signaling, placing Tbx5 activity
upstream or parallel to Hh-signaling. Gas1 was identified as
a Tbx5 downstream target (Figures 5 and 6), providing evidence
that Tbx5 acts upstream of Hh-signaling in the SHF, and Osr1,
a zinc finger transcription factor required for atrial septation,
was identified as a direct Tbx5 target in the SHF. Taken together,
these observations define Hh-dependent and parallel pathways
regulated by Tbx5 in SHF atrial septum progenitors required for
atrial septation. This work strengthens the recent paradigm
implicating SHF defects in the ontogeny of ASDs.
The question of where and when genes are required for
cardiac morphogenesis has significant consequences for under-
standing CHD ontogeny. Although cardiogenic transcription(F and G). Osr1 was expressed robustly in the pSHF and DMP (black arrow,
DMP reflection) and splanchnic mesothelium (red arrow, dorsal mesocar-
dium). At, atrium; OFT, outflow tract; SHF, second heart field. Magnification:
(D) and (E) = 1003; (F) and (G) = 4003.
(H) Expression of Osr1 is decreased in pSHF of Tbx5/+ (fold change, 0.41 ±
0.2, p < 0.05) and Shh/ embryos 0.5 ± 0.04, p < 0.05) compared to wild-type
embryos at E9.5 by real-time-PCR. Data are presented as mean ± SEM, n = 3.
(I) Tbx5 significantly stimulated firefly luciferase expression fromOsr1 genomic
fragments Osr1-F1 (5.82 ± 1.42; p = 0.0009) and Osr1-F4 (5.6 ± 1.02; p =
0.0009) compared to pGL3 empty vector (1.28 ± 0.49). Tbx5 did not stimulate
expression from Osr1 genomic fragments Osr1-F2 (1.4 ± 0.59; p = 0.61; p =
0.28) or Osr1-F3 (1.5 ± 0.41). Data are presented as mean ± SEM, n = 3. See
also Table S2.
(J) Tbx5 binds to Tbx5 responsive Osr1 genomic fragment in the SHF by ChIP-
PCR. The Tbx5-responsive DNA fragments were immunoprecipated by Tbx5
antibody and were amplified by real-time PCR. Osr1-F1 (98.14 ± 45.72) and
Osr1-F4 (82.54 ± 54.06) were significantly enriched compared to input DNA.
Data are presented as mean ± SEM, n = 3. See also Table S2.
(K) Schematic of mouse Osr1 including Tbx5 binding region (He et al., 2011)
adjacent to Osr1 and the cloned genomic fragments Osr1-F1-F4 tested for
Tbx5-dependent expression in-vitro (green bar). See also Table S2.
(L) Model of Tbx5 transcriptional regulation in atrial septation. Tbx5 acts
upstream of Hh-signaling, directly activating Gas1 expression. Tbx5 acts
parallel to Hh-signaling, directly activating Osr1 expression. Tbx5 also directly
activates Cdk6 in regulating atrial progenitor proliferation.
(M and N) Model for combinatorial role of Tbx5 and Hh-signaling in atrial
septation. Tbx5 promotes proliferation of pSHF inflow cardiac progenitors and
Hh-signaling. PSHF Hh-signal receiving Tbx5+Gli1+ cells are specified as atrial
septum progenitors and generate the atrial septum.
r Inc.
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the myocardium, we demonstrate that Tbx5 is required for atrial
septation in SHF cardiac progenitors. Endocardial knockout of
Tbx5 can cause secundum ASDs (Nadeau et al., 2010).
However, endocardial Tbx5 haploinsufficiency supported nor-
mal atrial septation (Figure 2). Thus, the SHF is more sensitive
to Tbx5 dose than the endocardium, suggesting a more signifi-
cant role for the SHF and more modest role for the endocardium
in ASDs caused by dominant Tbx5 mutations. Elucidating a
SHF role for Tbx5 in atrial septation provides momentum to
the paradigm describing the molecular events in SHF progeni-
tors as organizers of atrial septation (e.g., Snarr et al., 2007b;
Goddeeris et al., 2008; Hoffmann et al., 2009). We predict that
the requirement for other genes implicated in human ASDs
also resides in the SHF. For example, both Nkx2-5 and Gata4
are highly expressed in the SHF, particularly in the region over-
lapping Hh-receiving atrial septum progenitors in the pSHF and
later within the DMP (Kasahara et al., 1998; Kuo et al., 1997;
Ueyama et al., 2003). More generally, we speculate that molec-
ular diversity generated early among cardiac progenitors is
an organizer of structural cardiac morphogenesis that occurs
many days later.
Distinct Tbx5-Dependent Pathways in the SHF and in the
Heart
Our transcriptional profiling experiments provide evidence for
distinct Tbx5-dependent molecular pathways in the heart and
pSHF (Figure 4). Genes previously shown to be Tbx5 targets in
the heart, e.g., Nppa and Gja5 (Mori et al., 2006), were indepen-
dently identified in our profiling experiments (Figure 4). However,
expression of these intracardiac Tbx5 targets was unchanged by
Tbx5 dose in the pSHF (Figure 4). In contrast, a set of Tbx5 down-
stream genes is revealed in the pSHF, including a set of candi-
date genes with potential or known roles in atrial septation. For
example, we observed that expression of Gata6, required for
inflow tract development and atrial septation (Tian et al., 2010),
was Tbx5 dependent in the pSHF but not the heart, suggesting
that Gata6 may play its required role in the pSHF. Tbx5 has
also been shown to regulate cell proliferation in several develop-
mental contexts including the vertebrate heart (Goetz et al.,
2006; Hatcher et al., 2001). We observed that Tbx5 dependent
expression of multiple cell-cycle genes controlling progression
through M and G1 phases in the pSHF but not the heart, and
identified Cdk6 as a direct Tbx5 target. Cdk6 is not required for
cell-cycle progression, but instead potentates cell-cycle prog-
ress, often in response to signaling (reviewed in Kozar and Sicin-
ski, 2005). Our data support a model that Tbx5 is not part of the
core cell-cycle transcriptional kernel, but is able to engage it in
the pSHF to enhance cyclin-D kinase and other cell-cycle gene
expression to promote cell-cycle progression.
Tbx5 Acts Upstream of and Parallel to Hh-Signaling in
Atrial Septation
Tbx5-dependent molecular pathways required for atrial septa-
tion remained unknown despite the previous identification of
several Tbx5 transcriptional targets in the heart (Bruneau,
2003; Bruneau et al., 2001; Mori et al., 2006). We provide genetic
and molecular evidence that Tbx5 acts upstream and in parallel
to Hh-signaling in atrial septation. The genetic observation thatDevelopconstitutive Hh signaling can rescue Tbx5 removal in the pSHF
suggests that Hh signaling is sufficient to activate an atrial sep-
tation gene regulatory network (GRN) (Davidson and Erwin,
2006). This epistasis experiment (Figure 5) placed Tbx5 up-
stream and/or in parallel to Hh-signaling, and we discovered
molecular support for both possibilities. Tbx5 is required for
pSHF expression of genes required for normal Hh-signaling
(Gli1, Ptch1, Gas1) (Figure 6A) and Tbx5 directly activated
Gas1 transcription (Figure 6B). We concluded that Tbx5 potenti-
ated Hh-signaling. However, the modest scale of these effects
suggested that Tbx5 was not absolutely required for pSHF Hh-
signaling and implied that Tbx5 also acted in anHh-independent
pathway (Figure 6L). A molecular link to a parallel pathway was
identified in Osr1, a direct Tbx5 downstream target required for
atrial septation (Figure 6).
These observations demonstrate that Tbx5 acts both up-
stream and in parallel to Hh-signaling during inflow morphogen-
esis. The molecular findings are consistent with the broader
expression of Tbx5 in the pSHF than Gli1 (Figure 1) and the
more severe inflow phenotype of Tbx5 (Bruneau et al., 2001)
compared to Shh knockout mice (Washington Smoak et al.,
2005). The broader role for Tbx5 in cardiac inflow development,
upstream and parallel action of Tbx5 with respect to Hh sig-
naling, and capacity of Hh-signaling to autonomously activate
an atrial septation GRN suggest a model for the molecular
control of atrial septation (Figure 6): that Tbx5 establishes a
progenitor field and promotes Hh-signaling, which then selects
progenitors specific for the atrial septum (Figures 6M and 6N).
This work generates a working model for understanding the
molecular ontogeny of human ASDs.
EXPERIMENTAL PROCEDURES
Mouse Lines
Mice were a mixed B6/129/SvEv background. Tbx5/+, Tbx5fl/+, Gli1CreERT2/+,
Tie2Cre/+, the TnTCre/+ and the Mef2CCre/+ mouse lines have been reported
(Bruneau et al., 2001; Ahn and Joyner, 2004; Jiao et al., 2003; Kisanuki
et al., 2001; Verzi et al., 2005). Smofl, Smo-M2fl/fl, and Shh/+ mice were ob-
tained from The Jackson Laboratory. Mouse experiments were completed
according to a protocol reviewed and approved by the Institutional Animal
Care and Use Committee of the University of Chicago, in compliance with
the USA Public Health Service Policy on Humane Care and Use of Laboratory
Animals.
Microdissection of pSHF and RNA Extraction
Embryos were dissected above the outflow tract and below the inflow tract to
obtain a thoracic section including the heart. The neural tube was removed by
cutting through the foregut. Cutting between the outflow and inflow tracts
separated the pSHF and aSHF. The heart, aSHF, and pSHF were collected
separately in RNA-later.
In Situ Hybridization
In situ hybridization was performed as described in (Moorman et al., 2001).
Specifically, sense and antisense probes were generated using a digoxigenin
(DIG) RNA labeling kit (Roche). Probes were hybridized overnight at 65C onto
E9.5 or E10.5 embryo for both whole mount and section in situ hybridization.
DIG-labeled probes were detected by anti-digoxin-AP Fab fragments (Roche)
and precipitated by BM purple AP substrate (Roche).
Real-Time PCR
Reverse transcription reaction was performed using a SuperScript III Reverse
Transcriptase kit from Invitrogen. Real-time PCR was performed using a
POWER SYBER Green PCR mater mix from Applied Biosystems.mental Cell 23, 280–291, August 14, 2012 ª2012 Elsevier Inc. 289
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Three independent pools of RNA from each biological group were chosen for
cRNA amplification and Cyanine-3 labeling using Agilent Quick Amp Labeling
kit. Samples were profiled on Agilent Mouse Whole Genome Arrays. One pool
was discarded from analysis because of failure to Raw intensity data was
normalized using Agilent’s Feature extraction software. Data quality was
analyzed by assessing data distributions and Q-Q plots between replicates.
R statistical package SAM was used to detect differential expressed genes
and package GSA was used for gene set enrichment analysis (Tusher et al.,
2001; Efron and Tibshirani, 2001).
Immunohistochemistry
Embryos at E9.5 were stained with X-gal (Hoffmann et al., 2009) and sectioned
serially at 6 mm. For BrdU incorporation, pregnant mice were given 150 ml BrdU
solution at E9.0 with two doses, 3 hr and 6 hr before sacrifice, respectively. The
BrdU staining was performed using a BrdU In Situ detection kit (BD Pharmin-
gen). For TUNNEL staining, an ApopTag plus peroxidase In Situ apoptosis
detection kit was used (Chemicon). A rabbit anti-mouse p-Histone-H3
(ser10) (Abcam) and an Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen)
were used for cell-cycle staining.
Dual Luciferase Reporter Assay
Amplified promoter regions are noted in the results text was cloned into pGL3
Basic vector (Promega) modified to include a minimal TA promoter. Tbx5 was
cloned from a mouse atrial cDNA library into pcDNA3.1 Hygro (Invitrogen).
Transient transfections were performed in HEK293T cells using FuGene HD
(Promega) according to the manufacturer’s instructions. Total cell lysates
were prepared 48 hr posttransfection and luciferase activity was assessed
using the Promega Dual Luciferase Reporter kit (Promega) according to the
manufacturer’s protocol.
Chromatin Immunoprecipitation
Anti-protein G Dynabeads (Invitrogen) were prebound overnight to an anti-
Tbx5 antibody (Santa Cruz). Fifty E10 wild-type CD-1 embryos were isolated
in cold PBS with protease inhibitor, and the SHF was microdissected. Tissues
were crosslinked in 1.8% formaldehyde solution for 10 min, lysed, sonicated,
and incubated with beads overnight. Beads were magnetically precipitated
and washed. DNA was eluted from beads using 1% SDS/0.1 M NaHCO3,
de-crosslinked with 0.2 M NaCl at 65 centi-degrees and isolated using
a PCR clean up kit (QIAGEN). Enrichment was assayed by SYBR green
qPCR (Applied Biosystems).
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